← back to search

Rana Fayyad

Siemens Healthineers (Germany) · DE
Area of research
Surgery · Pharmacology
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Treatment of Major Depression, Diabetes, Cardiovascular Risks, and Lipoproteins, and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.
h-index
34
citations
4,873
works
115
NIH funding
primary concept
email

Recent publications

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
The Lancet 2023cited by 247position: middledoi
Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials
Journal of the American Heart Association 2019cited by 28position: middledoi
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
Circulation Cardiovascular Quality and Outcomes 2018cited by 77position: middledoi
Body-Weight Fluctuations and Outcomes in Coronary Disease
New England Journal of Medicine 2017cited by 312position: middledoi
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
European Heart Journal 2017cited by 120position: middledoi
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events
Journal of clinical lipidology 2017cited by 76position: middledoi
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial
The American Journal of Cardiology 2016cited by 81position: middledoi
An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder
International Clinical Psychopharmacology 2016cited by 19position: middledoi
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
The American Journal of Medicine 2015cited by 49position: middledoi
Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials
The American Journal of Cardiology 2014cited by 58position: middledoi
Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials
The American Journal of Cardiology 2014cited by 41position: middledoi
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease
The American Journal of Medicine 2013cited by 90position: middledoi
A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites
Neuropsychopharmacology 2012cited by 72position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David D. Waters · San Francisco General Hospital8 papers (2014–2019)David A. DeMicco · Pfizer (United States)8 papers (2013–2019)Sripal Bangalore · Hinge Health8 papers (2013–2019)Rachel Laskey · San Francisco General Hospital7 papers (2013–2017)Franz H. Messerli · University of Bern3 papers (2013–2017) · 2 papers (2017–2019)G Kees Hovingh · Amgen (United States)2 papers (2014–2019)Liffert Vogt · Erasmus University Rotterdam2 papers (2014–2019)John J.P. Kastelein · QRx Pharma (United States)2 papers (2015–2016)L Wiśniewski · University of South Carolina1 papers (2017–2017)Thomas F. Lüscher · Immunologie-Zentrum Zürich1 papers (2017–2017) · 1 papers (2012–2012)A. Michael Lincoff · Cleveland Clinic1 papers (2017–2017)Josep L. Carrasco · Virginia Commonwealth University1 papers (2016–2016)Jerry Shapiro · New York University1 papers (2023–2023)Helen M. Colhoun · Cleveland Clinic1 papers (2018–2018) · 1 papers (2017–2017)Nanette K. Wenger · Emory University1 papers (2014–2014)John B. Kostis · Rutgers, The State University of New Jersey1 papers (2013–2013)Joan Mackell · Virginia Commonwealth University1 papers (2016–2016)